Advertisement

Topics

High platelet reactivity to clopidogrel associated with greater risk of stent thrombosis, MI

11:46 EDT 22 Aug 2017 | Cardiovascular Business

Patients demonstrating high platelet reactivity (HPR) on clopidogrel are more likely to suffer stent thrombosis (ST) or MI within two years of stent implantation, according to a new study in JACC: Cardiovascular Interventions.

Original Article: High platelet reactivity to clopidogrel associated with greater risk of stent thrombosis, MI

NEXT ARTICLE

More From BioPortfolio on "High platelet reactivity to clopidogrel associated with greater risk of stent thrombosis, MI"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...